FDA-Inspected Site

Palo Alto Medical Foundation Reproductive Endocrinology and Infertility

6 FDA inspections are on record for Palo Alto Medical Foundation Reproductive Endocrinology and Infertility in San Jose, United States.

483· Form 483 issued

San Jose, United States · Last updated August 15, 2026

Overview

  • 6 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2026-06-18.

At a glance

Inspections

6

Form 483s

2

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
17 Jun 2026 – 18 Jun 2026Biologics483View 483 →
10 May 2023BiologicsClean
16 Aug 2017 – 17 Aug 2017Biologics483View 483 →
15 Jun 2015BiologicsClean
7 Jun 2012Not recordedClean
13 Aug 2009Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

18 Jun 2026
21 CFR 1271.75(a)(1)

Risk factors, clinical evidence

Cited by Melsomar R Ramos

18 Jun 2026
21 CFR 1271.75(d)

Donors with risks not determined ineligible

Cited by Melsomar R Ramos

17 Aug 2017
21 CFR 1271.75(a)(1)

Risk factors, clinical evidence

Cited by Amanda B Athey

17 Aug 2017
21 CFR 1271.75(a)(1)

Risk factors, clinical evidence

Cited by Amanda B Athey

Investigators

FDA investigators tied to this site in the record.

Jennifer H Rhyu1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 1271.75(a)(1)Cited across public-safe Form 483 observations3x
21 CFR 1271.75(d)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind this site's 2 Form 483s

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat